..read more

..read more

Tuesday, 26 March 2024 3:00 PM – 4:00 PM CET How much do you know about digital pathology and the multi-omics age for biomarkers discovery in HCC? Save your seat for the next ILCA webinar and engage in an insightful discussion with Julien Calderaro, Ankur Sharma, and Irene Ng to unlock the future of biomarker discovery in Hepatocellular Carcinoma. Free for ILCA Members! Register Now Webinar chairs Valerie Chew, Principal Investigator Translational Immunology Institute (TII), SingHealth-DukeNUS, Singapore       Tim Greten, senior Investigator, Co-Director, NCI CCR Liver ..read more

At the ILCA 2024 Single Topic Workshop. you can expect to learn more on treatment selection for BTC, hear on rare subtypes of liver cancer and much more! Check what our speakers have to say and make sure to read the full STW24 programme. Will you be there? Save your seat to learn more on sistemic therapy at STW24 Selection of first-line therapy for BTC with Mairead McNamara 26th April | 10.00 – 10.20 AM CET “Standard of care treatment for fit patients with biliary tract cancer (BTC) in the first-line advanced setting had remained Cisplatin/Gemcitabine for over a ..read more

April is just around the corner and we’re excited to provide you with a sneak peek into what awaits you in Madrid on 26-27 April at the ILCA Single Topic Workshop. Read some insightful quotes from our esteemed speakers, offering a glimpse into the cutting-edge discussions and advancements that will enrich the workshop’s programme. Get your ticket Selection of second-line therapy HCC with Massimo Iavarone 26th April | 09.40 – 10.00 AM CET “Over the last four years, the scenario of first-line treatment options for advanced hepatocellular carc ..read more

..read more

..read more

..read more

..read more

..read more